Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Science (New York, N.Y.)
|
June 30, 1995
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells
F Palombo, P Gallinari, I Iaccarino, et al.
Molecular Pharmacology
|
August 4, 1998
Involvement of the mismatch repair system in temozolomide-induced apoptosis
S D'Atri, L Tentori, P M Lacal, et al.
Carcinogenesis
|
July 27, 2001
hMSH3 overexpression and cellular response to cytotoxic anticancer agents
R Pepponi, G Graziani, S Falcinelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide
G Marra, S D'Atri, C Corti, et al.
Nature Communications
|
February 10, 2022
Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair
J Ferreira da Silva, G P Oliveira, E A Arasa-Verge, et al.
DNA Repair
|
May 22, 2012
Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency
P Vasovcak, A Krepelova, M Menigatti, et al.
International Journal of Cancer
|
January 15, 1988
Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias
H P Senn, C Trân-Thang, A Wodnar-Filipowicz, et al.
International Journal of Cancer
|
February 20, 1997
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers
L Losi, M Ponz de Leon, J Jiricny, et al.
Genes, Chromosomes & Cancer
|
September 17, 1998
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents
L Levati, G Marra, T Lettieri, et al.
Cancer Research
|
April 18, 2001
Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer
P Schweizer, A L Moisio, S A Kuismanen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Science (New York, N.Y.)
|
June 30, 1995
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells
F Palombo, P Gallinari, I Iaccarino, et al.
Molecular Pharmacology
|
August 4, 1998
Involvement of the mismatch repair system in temozolomide-induced apoptosis
S D'Atri, L Tentori, P M Lacal, et al.
Carcinogenesis
|
July 27, 2001
hMSH3 overexpression and cellular response to cytotoxic anticancer agents
R Pepponi, G Graziani, S Falcinelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide
G Marra, S D'Atri, C Corti, et al.
Nature Communications
|
February 10, 2022
Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair
J Ferreira da Silva, G P Oliveira, E A Arasa-Verge, et al.
DNA Repair
|
May 22, 2012
Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency
P Vasovcak, A Krepelova, M Menigatti, et al.
International Journal of Cancer
|
January 15, 1988
Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias
H P Senn, C Trân-Thang, A Wodnar-Filipowicz, et al.
International Journal of Cancer
|
February 20, 1997
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers
L Losi, M Ponz de Leon, J Jiricny, et al.
Genes, Chromosomes & Cancer
|
September 17, 1998
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents
L Levati, G Marra, T Lettieri, et al.
Cancer Research
|
April 18, 2001
Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer
P Schweizer, A L Moisio, S A Kuismanen, et al.
Page
of 10